share_log

Biofrontera Doses First Patient in Phase 3 Actinic Keratosis Clinical Trial

Biofrontera Doses First Patient in Phase 3 Actinic Keratosis Clinical Trial

Biofrontera 在 3 期光化角化病临床试验中为首位患者接种
MT Newswires ·  2023/01/09 17:32

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发